AMAG Pharmaceuticals Company Profile (NASDAQ:AMAG)

About AMAG Pharmaceuticals

AMAG Pharmaceuticals logoAMAG Pharmaceuticals, Inc. is a pharmaceutical company. The Company's segment is the manufacture, development and commercialization of products and services for use in treating various conditions, with a focus on maternal health, anemia management and cancer supportive care. Its offerings focus on maternal health, anemia management and cancer supportive care, including its product, Makena (hydroxyprogesterone caproate injection); services related to the collection, processing and storage of umbilical cord blood stem cell and cord tissue units operated through Cord Blood Registry (CBR); its product, Feraheme (ferumoxytol), for intravenous (IV) use, and MuGard Mucoadhesive Oral Wound Rinse. It is engaged in the development of Digoxin immune fab, a polyclonal antibody for the treatment of severe preeclampsia in pregnant women. Makena is a drug indicated to reduce the risk of preterm birth in women pregnant with a single baby having a history of singleton spontaneous preterm birth.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Diagnostic Substances
  • Sub-Industry: Biotechnology
  • Exchange: NASDAQ
  • Symbol: AMAG
  • CUSIP: 00163U10
Key Metrics:
  • Previous Close: $24.16
  • 50 Day Moving Average: $24.48
  • 200 Day Moving Average: $23.78
  • 52-Week Range: $34,154,000.00 - $17.92
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: 7.60
  • P/E Growth: -2.60
  • Market Cap: $827.89M
  • Outstanding Shares: 34,154,000
  • Beta: 0.53
Profitability:
  • Net Margins: -4.87%
  • Return on Equity: 13.98%
  • Return on Assets: 5.16%
Debt:
  • Debt-to-Equity Ratio: 1.03%
  • Current Ratio: 2.24%
  • Quick Ratio: 2.11%
Additional Links:
Companies Related to AMAG Pharmaceuticals:

Analyst Ratings

Consensus Ratings for AMAG Pharmaceuticals (NASDAQ:AMAG) (?)
Ratings Breakdown: 5 Hold Ratings, 5 Buy Ratings
Consensus Rating:Buy (Score: 2.50)
Consensus Price Target: $38.13 (57.28% upside)

Analysts' Ratings History for AMAG Pharmaceuticals (NASDAQ:AMAG)
Show:
DateFirmActionRatingPrice TargetDetails
8/10/2016Jefferies GroupLower Price TargetBuy$58.00 -> $45.00View Rating Details
5/9/2016Deutsche Bank AGLower Price TargetHold$42.00 -> $35.00View Rating Details
5/5/2016JPMorgan Chase & Co.Reiterated RatingHold$37.00View Rating Details
5/4/2016Leerink SwannLower Price TargetOutperform$45.00 -> $40.00View Rating Details
5/4/2016Raymond James Financial Inc.DowngradeOutperform -> Market PerformView Rating Details
3/28/2016Robert W. BairdLower Price TargetOutperform$26.00 -> $25.00View Rating Details
3/28/2016Ladenburg ThalmannDowngradeBuy -> NeutralView Rating Details
2/18/2016GuggenheimLower Price TargetBuy$54.00 -> $51.00View Rating Details
1/28/2016Northland SecuritiesInitiated CoverageOutperform$40.00View Rating Details
1/21/2016Barclays PLCInitiated CoverageEqual Weight$32.00View Rating Details
3/9/2015Cowen and CompanyInitiated CoverageOutperformView Rating Details
1/26/2015FBR & CoReiterated RatingMarket Perform$42.00View Rating Details
(Data available from 9/26/2014 forward)

Earnings

Earnings History for AMAG Pharmaceuticals (NASDAQ:AMAG)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/1/2016        
8/9/2016Q216$1.20$1.45$128.52 million$127.40 millionViewListenView Earnings Details
5/3/2016Q116$1.11$0.94$124.83 million$117.60 millionViewListenView Earnings Details
2/17/2016Q415$1.16$1.12$120.13 million$108.70 millionViewListenView Earnings Details
11/3/2015Q315$1.21$1.02$113.88 million$103.50 millionViewListenView Earnings Details
7/23/2015Q215$0.75$1.12$94.05 million$123.90 millionViewListenView Earnings Details
5/5/2015Q115$1.04$1.11$84.66 million$89.50 millionViewListenView Earnings Details
2/9/2015Q414$0.30$0.06$52.69 million$53.30 millionViewListenView Earnings Details
10/30/2014Q314($0.08)$0.06$26.30 million$25.50 millionViewListenView Earnings Details
7/29/2014Q214($0.09)($0.07)$23.40 million$24.80 millionViewListenView Earnings Details
4/24/2014Q1($0.07)($0.33)$22.73 million$20.80 millionViewListenView Earnings Details
2/6/2014Q4($0.10)($0.17)$21.01 million$21.70 millionViewListenView Earnings Details
10/17/2013Q313($0.12)($0.01)$20.37 million$21.60 millionViewListenView Earnings Details
8/1/2013Q2 2013($0.17)($0.09)$18.51 million$19.60 millionViewListenView Earnings Details
4/23/2013Q1 2013($0.20)($0.18)$17.99 million$17.90 millionViewListenView Earnings Details
3/1/2013Q4 2012($0.06)($0.17)$22.54 million$21.14 millionViewN/AView Earnings Details
11/1/2012Q312($0.26)($0.19)$20.43 million$17.70 millionViewN/AView Earnings Details
7/26/2012($0.39)$0.16ViewN/AView Earnings Details
5/1/2012($0.63)($0.58)ViewN/AView Earnings Details
3/5/2012($1.09)($0.87)ViewN/AView Earnings Details
11/4/2011($0.98)($0.78)ViewN/AView Earnings Details
5/3/2011($0.99)($1.05)ViewN/AView Earnings Details
2/25/2011($1.04)($0.94)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for AMAG Pharmaceuticals (NASDAQ:AMAG)
Current Year EPS Consensus Estimate: $0.67 EPS
Next Year EPS Consensus Estimate: $3.19 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20165$0.13$0.68$0.36
Q2 20163$0.14$0.76$0.54
Q3 20163$0.38$0.90$0.71
Q4 20163$0.44$1.06$0.83
(Data provided by Zacks Investment Research)

Dividends

Dividend History for AMAG Pharmaceuticals (NASDAQ:AMAG)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for AMAG Pharmaceuticals (NASDAQ:AMAG)
Insider Ownership Percentage: 2.30%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
11/10/2015John A FallonDirectorBuy3,230$31.20$100,776.00View SEC Filing  
10/1/2015William K HeidenCEOSell2,000$39.69$79,380.00View SEC Filing  
9/1/2015William K HeidenCEOSell2,000$61.19$122,380.00View SEC Filing  
7/15/2015William K HeidenCEOSell20,000$75.00$1,500,000.00View SEC Filing  
6/15/2015Scott A HolmesSVPSell7,580$66.63$505,055.40View SEC Filing  
6/5/2015William K HeidenCEOSell66,875$69.90$4,674,562.50View SEC Filing  
6/4/2015Frank E ThomasCOOSell20,000$69.47$1,389,400.00View SEC Filing  
6/3/2015Scott A HolmesSVPSell22,516$68.88$1,550,902.08View SEC Filing  
1/9/2015Adage Capital Partners Gp LlcMajor ShareholderSell1,250,000$46.49$58,112,500.00View SEC Filing  
1/9/2014Christopher WhiteInsiderSell4,000$22.37$89,480.00View SEC Filing  
1/7/2014Christopher WhiteInsiderSell5,000$23.90$119,500.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for AMAG Pharmaceuticals (NASDAQ:AMAG)
DateHeadline
newsmaker.com.au logo2016 H2 Premature Labor (Tocolysis) Pipeline Market Therapeutics Outlook Research (NASDAQ:AMAG)
www.newsmaker.com.au - September 23 at 3:53 PM
News IconEarnings According to Analysts for AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG)? - Frisco Fastball (NASDAQ:AMAG)
friscofastball.com - September 22 at 3:25 PM
News IconAMAG Pharmaceuticals, Inc. (AMAG) Forecasted to Post Q4 2016 Earnings of $0.60 Per Share - DailyQuint (NASDAQ:AMAG)
dailyquint.com - September 20 at 3:25 PM
News IconJefferies Group Equities Analysts Reduce Earnings Estimates for AMAG Pharmaceuticals, Inc. (AMAG) - DailyQuint (NASDAQ:AMAG)
dailyquint.com - September 19 at 4:21 PM
News IconGlobal Intravenous (IV) Iron Drugs Market size and forecast By 2020 (NASDAQ:AMAG)
www.medgadget.com - September 14 at 8:58 AM
live-pr.com logoNew Market Research Report: AMAG Pharmaceuticals, Inc. (AMAG) - Medical Equipment - Deals and Alliances Profile (NASDAQ:AMAG)
www.live-pr.com - September 14 at 8:58 AM
News IconAMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) Becomes A Growth ... - National Daily Press (NASDAQ:AMAG)
www.nationaldailypress.com - September 9 at 8:16 AM
News IconStock Slipping Down Over the Past Five Trading Sessions: AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) - National Daily Press (NASDAQ:AMAG)
www.nationaldailypress.com - September 9 at 8:16 AM
News IconPlacing AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) Shares Under the Microscope - Post News (NASDAQ:AMAG)
www.kentuckypostnews.com - September 8 at 3:27 PM
News IconLooking Ahead for AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG ... - Frisco Fastball (NASDAQ:AMAG)
friscofastball.com - September 8 at 3:27 PM
nasdaq.com logoAMAG Pharmaceuticals Appoints Tony Casciano as Senior Vice President of Hematology/Oncology Sales and Marketing - Nasdaq (NASDAQ:AMAG)
www.nasdaq.com - September 7 at 8:35 PM
globenewswire.com logoAMAG Pharmaceuticals Appoints Tony Casciano as Senior Vice President of Hematology/Oncology Sales and Marketing - GlobeNewswire (press release) (NASDAQ:AMAG)
globenewswire.com - September 7 at 12:24 PM
publicnow.com logoAMAG Pharmaceuticals Appoints Tony Casciano as Senior Vice President of Hematology/Oncology Sales and Marketing (NASDAQ:AMAG)
www.publicnow.com - September 7 at 12:24 PM
capitalcube.com logoETF’s with exposure to AMAG Pharmaceuticals, Inc. : September 6, 2016 (NASDAQ:AMAG)
www.capitalcube.com - September 6 at 3:25 PM
finance.yahoo.com logoAMAG Pharmaceuticals to Present at Upcoming Investor Conference - Yahoo Finance (NASDAQ:AMAG)
finance.yahoo.com - September 2 at 8:07 AM
News IconStock in Review: Taking a Closer Look at AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) Shares - Post News (NASDAQ:AMAG)
www.kentuckypostnews.com - September 1 at 11:55 AM
News IconAMAG Pharmaceuticals to Present at Upcoming Investor Conference - EconoTimes (NASDAQ:AMAG)
www.econotimes.com - September 1 at 11:55 AM
publicnow.com logoAMAG Pharmaceuticals to Present at Upcoming Investor Conference (NASDAQ:AMAG)
www.publicnow.com - September 1 at 11:55 AM
News IconAMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) Upcoming Earnings ... - The Voice Registrar (NASDAQ:AMAG)
voiceregistrar.com - August 31 at 8:15 AM
insidermonkey.com logoWhy Do Hedge Funds Like AMAG Pharmaceuticals? - Insider Monkey (blog) (NASDAQ:AMAG)
www.insidermonkey.com - August 30 at 3:27 PM
News IconWhy Do Hedge Funds Like AMAG Pharmaceuticals? (NASDAQ:AMAG)
feedproxy.google.com - August 30 at 9:37 AM
News IconMedical Nanotechnology Market Growth, Trend, Share & Forecast Research Report till 2022 (NASDAQ:AMAG)
www.medgadget.com - August 29 at 8:13 AM
News IconKey Trends, Challenges of Global Intravenous (I.V.) Iron Drugs Market 2015 (NASDAQ:AMAG)
www.emailwire.com - August 28 at 3:24 PM
News IconAMAG Pharmaceuticals, Inc.'s (AMAG): Intraday Mover - Hot Stocks Point (NASDAQ:AMAG)
www.hotstockspoint.com - August 26 at 3:26 PM
capitalcube.com logoAMAG Pharmaceuticals, Inc. breached its 50 day moving average in a Bearish Manner : AMAG-US : August 25, 2016 (NASDAQ:AMAG)
www.capitalcube.com - August 25 at 8:16 AM
capitalcube.com logoETF’s with exposure to AMAG Pharmaceuticals, Inc. : August 24, 2016 (NASDAQ:AMAG)
www.capitalcube.com - August 24 at 3:29 PM
investornewswire.com logoWill AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) Surprise Analysts? - Investor Newswire (NASDAQ:AMAG)
www.investornewswire.com - August 20 at 3:30 PM
finance.yahoo.com logoAMAG PHARMACEUTICALS INC. Financials (NASDAQ:AMAG)
finance.yahoo.com - August 18 at 3:35 PM
News IconThe Statistics Don't Lie: AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) Earnings Preview - The Voice Registrar (NASDAQ:AMAG)
voiceregistrar.com - August 17 at 3:29 PM
capitalcube.com logoAMAG Pharmaceuticals, Inc. :AMAG-US: Earnings Analysis: Q2, 2016 By the Numbers : August 12, 2016 (NASDAQ:AMAG)
www.capitalcube.com - August 12 at 3:39 PM
capitalcube.com logoETF’s with exposure to AMAG Pharmaceuticals, Inc. : August 12, 2016 (NASDAQ:AMAG)
www.capitalcube.com - August 12 at 3:39 PM
News IconAMAG Pharmaceuticals Inc. (NASDAQ: AMAG) reports quarterly earnings - BNB Daily (blog) (NASDAQ:AMAG)
www.baseball-news-blog.com - August 11 at 3:30 PM
fool.com logoWhy AMAG Pharmaceuticals, Inc. Is Tanking Today - Motley Fool (NASDAQ:AMAG)
www.fool.com - August 11 at 12:42 PM
capitalcube.com logoAMAG Pharmaceuticals, Inc. breached its 50 day moving average in a Bearish Manner : AMAG-US : August 11, 2016 (NASDAQ:AMAG)
www.capitalcube.com - August 11 at 12:42 PM
insidermonkey.com logoAMAG Pharmaceuticals, Inc. (AMAG) Is An Attractive Contrarian Entry (NASDAQ:AMAG)
www.insidermonkey.com - August 11 at 12:42 PM
fool.com logoWhy AMAG Pharmaceuticals, Inc. Is Tanking Today (NASDAQ:AMAG)
www.fool.com - August 10 at 9:55 PM
fortune.com logoAnalyst Ratings On Watch List: AMAG Pharmaceuticals, Inc ... - Review Fortune (NASDAQ:AMAG)
reviewfortune.com - August 10 at 10:34 AM
News IconMost Volatile Healthcare Stocks- AMAG Pharmaceuticals (NASDAQ:AMAG), Arrowhead Pharmaceuticals (NASDAQ ... - Seneca Globe (NASDAQ:AMAG)
www.senecaglobe.com - August 10 at 10:34 AM
streetupdates.com logoNotable Analysts Recommendation to Monitor: AMAG ... - Street Updates (NASDAQ:AMAG)
www.streetupdates.com - August 10 at 10:34 AM
News IconAMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) & Ionis Pharmaceuticals Inc (NASDAQ:IONS) Stocks Trending Alert - Money News (press release) (NASDAQ:AMAG)
www.newsismoney.com - August 10 at 10:34 AM
finance.yahoo.com logoEdited Transcript of AMAG earnings conference call or presentation 9-Aug-16 12:00pm GMT (NASDAQ:AMAG)
finance.yahoo.com - August 10 at 10:34 AM
globenewswire.com logoAMAG Pharmaceuticals Reports Second Quarter 2016 Financial Results and Provides Corporate Update (NASDAQ:AMAG)
globenewswire.com - August 9 at 12:12 PM
reuters.com logoBRIEF-Amag Pharmaceuticals qtrly loss per share $0.02 (NASDAQ:AMAG)
www.reuters.com - August 9 at 12:12 PM
cnbc.com logoAMAG Pharmaceuticals reports 2Q loss (NASDAQ:AMAG)
www.cnbc.com - August 9 at 12:12 PM
twst.com logoAMAG Pharmaceuticals Inc.: AMAG Pharmaceuticals Reports Second Quarter 2016 Financial Results and Provides Corporate Update (NASDAQ:AMAG)
www.twst.com - August 9 at 12:12 PM
feeds.benzinga.com logoAMAG Pharma Posts Big Q2 Beat On The Bottom Line (NASDAQ:AMAG)
feeds.benzinga.com - August 9 at 9:34 AM
ftsenews.co.uk logoAMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) Updated Price Targets - FTSE News (NASDAQ:AMAG)
www.ftsenews.co.uk - August 5 at 8:51 PM
News IconThe Statistics Don't Lie: AMAG Pharmaceuticals, Inc. (NASDAQ ... - The Voice Registrar (NASDAQ:AMAG)
voiceregistrar.com - August 5 at 8:51 PM
News IconUpcoming Earnings Report: AMAG Pharmaceuticals (NASDAQ:AMAG) - The Voice Registrar (NASDAQ:AMAG)
voiceregistrar.com - August 2 at 3:28 PM
prnewswire.com logoHow These Healthcare Stocks are Performing? -- AMAG Pharma, IDEXX Laboratories, Neogenomics, and ICON - PR Newswire (press release) (NASDAQ:AMAG)
www.prnewswire.com - July 30 at 3:32 PM

Social

AMAG Pharmaceuticals (NASDAQ:AMAG) Chart for Monday, September, 26, 2016


Last Updated on 9/26/2016 by MarketBeat.com Staff